TITLE:
Study Of Ispinesib In Subjects With Breast Cancer

CONDITION:
Breast Cancer

INTERVENTION:
Ispinesib

SUMMARY:

      The purpose of this research study is to find how breast cancer responds to the
      investigational drug, Ispinesib. An investigational drug is a drug that has not been
      approved by the Food and Drug Administration (FDA) and is available for research use only.
      In particular, this study will try is to find the answers to the following research
      questions:

        1. Does breast cancer respond to Ispinesib?

        2. What are the side effects of Ispinesib?

        3. How much Ispinesib is in the blood at specific times after it is taken?
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Stage IIIB or Stage IV breast cancer

          -  Previously received anthracycline and taxane therapy

        Exclusion criteria:

          -  Actively receiving anti-cancer therapy agent(s).
      
